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In these last years, along with the description of new NK cell types
playing key roles within different body compartments, it is becom-
ing conceivable that NK cell receptors might have been shaped to
fulfill a complex array of functions beyond the simple recognition
of pathological cells (1, 2). Such a process of adaptation to multiple
needs offers new unexpected viewpoints on the evolution of NK
receptors and their possible exploitation in a growing range of dis-
eases. The first article of the present Research Topic will introduce
this concept by providing a general discussion on how the major
groups of receptors can be used by NK cells inside or outside the
classical natural killing function (3). The following articles will go
into detail of the various NK cell functions and the involved NK
cell subsets, primarily considering the pressure exerted by physi-
ological or pathological stimuli on the related receptors and their
specific ligands.
Li and Mariuzza (4) describe the crystal structures of several
surface receptors, belonging to the most known NK receptor fam-
ilies, and explain how such information could be critical for the
prediction of possible molecular interactions with either extracel-
lular ligands or intracellular signaling molecules. Cassidy et al. (5)
focus on the KIR ligands, the MHC-I molecules, and analyze the
role of the MHC-I peptide content in such receptor/ligand inter-
action suggesting that also NK cells can perceive in some ways
intracellular modifications in tumor or virally infected cells.
Whether the peptide could also have a role in the HLA-I
recognition by activating KIRs (aKIRs) is still unclear. Neverthe-
less, aKIRs are likely to play a role in infectious diseases, cancer,
and autoimmunity. For example, aKIRs-mediated recognition of
viruses and consequent NK cell priming has been proposed to
occur and to be directly involved in the pathogenesis of the
chronic lymphoproliferative disorder of NK cells (CLPD-NK)
(6). Remarkably, several CLPD-NK cases present an expansion of
aKIR+ NK cells, which are, nevertheless, characterized by reduced
NCR-mediated function. In this context, aKIRs have been recently
shown to participate in the education of NK cells, rendering them
hyporesponsive. Interestingly, education by aKIRs shares features
with the hyporesponsiveness induced by chronic stimulation of
other activating receptors expressed by NK cells (7).
All the above mentioned articles can provide hints on the
process of co-evolution that may have affected KIRs, their autol-
ogous ligands and exogenous molecules or peptides, as well as
the mechanisms controlling the strength of NK cell response to
stimuli. A possible receptor/ligand co-evolution may have also
concerned several non-MHC-specific activating receptors. A liv-
ing recapitulation of how this co-evolution may have occurred is
represented by the struggle between NK cells and tumors. Cer-
boni et al. (8) and Huergo-Zapico et al. (9) describe different
molecular pathways that can convey stress or damage signals to
enhance the expression of various ligands of NKG2D or DNAM-1
activating receptors. These signals are often related to the process
of tumor transformation. Bottino et al. (10), Baier et al. (11),
Chouaib et al. (12), and Chretien et al. (13) show that a large
part of the non-MHC-specific activating NK receptors can recog-
nize ligands overexpressed on tumors. On the other hand, they also
show that really many strategies are executed by the tumor to avoid
the NK cell attack. In the end, the authors indicate how a deeper
understanding of the forces involved in the NK/tumor struggle is
essential to develop more effective NK cell-based immunotherapy
against cancer.
Remarkably, the quantitative deficiency of NK cells or the
altered expression/function of their receptors witness the nega-
tive influence exerted not only by tumor microenvironment but
also by viruses. Lugli et al. (14) and Marras et al. (15) show that
viruses (i.e., HIV, HCV, and hCMV) are able to affect the func-
tional status and the homeostasis of NK cell population through
the modulation/engagement of several surface receptors and the
expansion of unconventional poorly functional NK cell subsets.
As above mentioned, because of their polyvalent role, certain
receptors may have been exposed to multiple shaping pressures.
For example, NK cells that populate decidua (dNK) in the first
trimester of pregnancy can use NKp44, NKp30, and KIR2DL4
both to control infections and to promote regulatory interactions
[with trophoblasts or dendritic cell (DC)] important for placental
development (16). The abundance of dNK cells in the decidua in
a specific phase of pregnancy suggests that these cells could be
determinant for a safe and successful childbirth, indicating that
reproduction may have significantly intervened on the evolution
of certain NK receptors. The dual role of certain NK receptors and
the promiscuity of their ligands have also been recently highlighted
by the characterization of the large family of innate lymphoid cells
(ILCs). Cella et al. (17) and Killig et al. (18) discuss this issue. ILCs
play a relevant role in the defense against invading microbes, but
also in tissue remodeling including the induction of lymphoid tis-
sues as well as the homeostasis of epithelial barrier in the mucose.
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They include two different NK-R+ cell types: the conventional
NK cells (belonging to group 1 ILCs) and the IL22-producing
NCR+ILC3 cells (belonging to group 3 ILCs). Depending on
the environmental mediators, engagement of NKp44 and PRRs
can mediate release of the ILC3 signature cytokine IL-22 or pro-
inflammatory soluble factors thus modulating both epithelial and
immune cell functions at mucosal interfaces.
Also, NKp30 can fulfill different tasks, as it can serve as a tool
for eliminating altered cells and promoting regulatory interac-
tion with autologous cells. Reiners et al. (19) shows that exosomes
derived from both tumor cells and activated DCs can play a rel-
evant role in the regulation of NK cell function. Interestingly,
in both cases, interaction of NKp30 with its ligand BAG6 on
exosomes can activate NK cells.
Different studies have highlighted the important immunomod-
ulatory role of the crosstalk between NK cells and DCs. Ferlazzo
and Morandi (20) describe the new DC subsets recently identified
in the human system and suggest that the NK/DC interactions
should be considered as a complex network of cell subset coopera-
tion acting in discrete regions of the body to fulfill complementary
tasks.
The functional interaction with normal cells (such as DCs
or trophoblasts) implies that several NK receptors can recognize
autologous ligands. These considerations indicate that a potential
role for NK cells also in the development of autoimmune diseases.
Poggi and Zocchi (21) and Enk and Mandelboim (22), respectively,
describe how the inappropriate interaction with APC or MSC and
the ectopic/abnormal expression of certain NCR-ligands could
be implied on several autoimmune diseases thus contributing to
widen the range of pathologies potentially involving NK cells.
In conclusion, the analysis of the NK cell functions and recep-
tors as discussed in this Research Topic indicates that, in spite of
the continuous flow of discoveries that have significantly changed
key concepts on the biology of NK cells, “the recognition of self,”
originally postulated by Kärre more than 20 years ago as strategy to
drive NK cell cytotoxicity (23), still represents the basis of NK cell
function. Exactly following this core strategy, NK cells have evolved
their wide range of receptors required to fulfill their ever increasing
number of functions. NK receptors mostly recognize autologous
ligands whose expression could be induced/regulated by stress,
viral infection, cell damage, or activating stimuli. Through these
interactions, NK receptors regulate the response to pathogens or
dangerous altered cells, but also take part to functional interactions
with different elements of peripheral tissues.
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